Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics

Open Access

Peer-reviewed

Research Article

Sabina S. Alistar ,

* E-mail: ssabina@stanford.edu

Affiliation Department of Management Science and Engineering, Stanford University, Stanford, California, United States of America
⨯
Douglas K. Owens,

Affiliations Veterans Affairs Palo Healthcare System, Palo Alto, California, United States of America, Center for Health Policy/Program on Clinical Outcomes Research, Stanford University, Stanford, California, United States of America
⨯
Margaret L. Brandeau

Affiliation Department of Management Science and Engineering, Stanford University, Stanford, California, United States of America
⨯

Reader Comments (0)

Pre-exposure prophylaxis
Is the Subject Area "Pre-exposure prophylaxis" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
HIV epidemiology
Is the Subject Area "HIV epidemiology" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
HIV prevention
Is the Subject Area "HIV prevention" applicable to this article?

Thanks for your feedback.